“…The 1-, 3-, and 5-year survival rates were evaluated in six [21,22,27,28,29,30], five [21,22,27,28,29], and four [21,22,27,28] studies, respectively. A random-effect model was used, and the pooled ORs for the 1-, 3-, and 5-year survival rates of the IPM group when compared with the non-IPM group were 0.65 (95% CI 0.45~0.94, P = 0.02; Fig 3A), 0.92(95% CI 0.59~1.45, P = 0.72; Fig 3B), and 0.93 (95% CI 0.65~1.34, P = 0.69; Fig 3C), respectively.…”